COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

CpG 7909/Montanide ISA 720 With or Without Cyclophosphamide in Combination Either With NY-ESO-1-derived Peptides or the NY-ESO-1 Protein for NY-ESO-1-expressing Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00819806
Recruitment Status : Completed
First Posted : January 9, 2009
Last Update Posted : July 31, 2017
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Hassane M. Zarour, MD, University of Pittsburgh

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : May 2012
Actual Study Completion Date : January 2015